Autoimmune disease are a result of a dysfunctional and hyperactive immune system. Caused primarily by auto-reactive T cells, they attack the self causing persistent inflammation and tissue damage.

Abgenics is developing antibodies (in all 3 formats) to block this action by targeting the auto-reactive T cells and the pathways they activate.